Side-by-side financials for CTXR and AZN. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CTXR | AZN |
|---|---|---|
| Market cap | - | $286.27 B |
| US-listed rank | - | #47 |
| Revenue (latest FY) | $90.00K | - |
| Net income (latest FY) | -$32.54M | - |
| Net margin | -36158.8% | - |
| SEC filings | 625 | 1,004 |
Full pages: Citius Pharmaceuticals, Inc. and AstraZeneca PLC, or browse the full rankings.